Bacterial lysis of Escherichia coli

Bacterial lysis of Escherichia coli is the process of cellular disintegration characterized by the rupture of the cell wall and plasma membrane, resulting in the release of internal contents (Wikipedia, 2023). This process is a critical endpoint for many bactericidal antibiotics, including beta-lactams, which compromise the structural integrity of the peptidoglycan layer by inhibiting penicillin-binding proteins (StatPearls, 2023). In Gram-negative organisms like E. coli, lysis also results in the liberation of lipopolysaccharides (LPS) from the outer membrane, which can act as potent endotoxins and trigger systemic inflammatory responses (PubMed, 2021). While essential for clearing infections, the rapid lysis of large bacterial populations can lead to clinical complications such as sepsis or the Jarisch-Herxheimer reaction (NIH, 2022). In laboratory settings, lysis is frequently employed for the recovery of intracellular products, though it is considered a biological outcome rather than a specific molecular drug target (Nature Reviews Microbiology, 2018).

Other names

E. coli lysisBacteriolysisCell wall disruptionOsmotic lysis

Inhibition of peptidoglycan cross-linking or direct membrane disruption leading to osmotic instability and cellular rupture.